Walmart to alter opioid prescription policies at its pharmacies
Date: 2018-05-08   Author: Ojaswita Kutepatil  Category: #news

Walmart to alter opioid prescription policies at its pharmacies

In a bid to curb opioid misuse and abuse, Walmart Inc., has announced that it will only fill first-time opioid prescriptions for acute pain to seven days or even less across the United States. Reportedly, the initiative will be commenced within 60 days and comes on the heels of the rising number of healthcare entities tightening the rules surrounding the filing of opioid prescriptions.

Sources reveal that pharmacies, beginning 1st January 2020, will be restricting the dosage of opioids to not more than 50 MMEs (morphine milligrams equivalent) per day and will require online prescriptions for controlled substances. The e-prescriptions are deemed to minimize error and prevent prescription frauds.  

Marybeth Hays, Walmart’s executive VP of health and wellness and consumables, was quoted stating that the company is taking action in the fight against the nation’s opioid epidemic. In an effort to continue to be a part of the solution, Walmart is introducing new programs, tools and policies that will be aimed at addressing the critical issues faced by the patients & communities.

Reliable reports claim that the initiatives will also be applicable to Sam’s Club Pharmacies, which is owned by Walmart. Several other companies have also been making similar efforts to help mitigate the opioid epidemic.

As per industry analysts, these proposals have disclosed that limitations are important to lower the number of painkillers that are available to be unlawfully diverted, stem overprescribing, and lower the potential for addiction.

Opioid overdose crisis and the proposal for its limits have garnered significant support from several shareholders, owing to which a bill in the Senate will be restricting the initial prescriptions for acute pain to 3 days.

Meanwhile, the AMA (American Medical Association) has countered that the limits over opioid dosage & supply are arbitrary and believes that the decision needs to be left between the physician and the patient.



About Author


Ojaswita Kutepatil

Ojaswita Kutepatil

Ojaswita Kutepatil, a mechanical engineer by qualification, worked as a BDE and Technical Engineer before switching her profession to content writing. Currently, she works at AlgosOnline. as an Content writer, where she pens down write-ups pertaining to the market res...

Read More

More from Ojaswita


Post Recommendents

Mindtree partners with Bengaluru’s IISc to support AI research
Author: Paroma Bhattacharya

Bengaluru-based IT service provider, Mindtree Ltd. has recently collaborated with the Indian Institute of Science (IISc), Bangalore to create an endowment focused on AI research, and facilitate teaching and resear...


Asia Pacific Passive Fire Protection Materials Market will grow at 9.5% CAGR up to 2024
Author: Rahul Varpe

Based on the end-users, building & construction segment for passive fire protection materials market is projected to grow with CAGR of about 8.5% by 2024. This is attributed to strong persistence by regional regulatory bodies primarily in emer...


Tata Group in talks of acquiring a controlling stake in Jet Airways
Author: Ojaswita Kutepatil

Tata Group is reportedly inspecting Jet Airways’ books as the multinational corporation considers to grow its footprint in India’s growing air travel sector by potentially purchasing a stake in the cash-str...